Total Funding
70
52
Total FundingDebt Financing raised
Growth Score
-6 pts
Heat Score
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
83765
CiRC Biosciences is a biotech company developing potential cell therapy treatments for vision loss conditions.
- Sai Chavala: Co-Founder and Chief Scientific Officer
About the Company
CiRC Biosciences operates in the biotechnology industry, focusing on the development of potential cell therapy treatments. The company is currently in the pre-clinical development stage for a treatment for retinitis pigmentosa (RP) and dry age-related macular degeneration. These conditions are related to vision loss, and CiRC Biosciences is working
on innovative solutions to address them. The company is a portfolio company of Paragon Biosciences.
